Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Michael J Krowka"'
Publikováno v:
Canadian Respiratory Journal, Vol 19, Iss 4, Pp 243-245 (2012)
Pulmonary alveolar proteinosis (PAP) is a disease of alveolar accumulation of phospholipoproteinaceous material that results in gas exchange impairment leading to dyspnea and alveolar infiltrates. There are three forms of PAP: congenital, acquired an
Externí odkaz:
https://doaj.org/article/886f6fcd18074f698d10ac0a5a286a9c
Autor:
Hilary M. DuBrock, MD, James R. Runo, MD, Corey J. Sadd, MD, Charles D. Burger, MD, Rodrigo Cartin-Ceba, MD, Charles B. Rosen, MD, Timucin Taner, MD, PhD, Scott L. Nyberg, MD, PhD, Julie K. Heimbach, MD, James Y. Findlay, MB, CHB, Michael J. Krowka, MD
Publikováno v:
Transplantation Direct, Vol 6, Iss 12, p e630 (2020)
Background. Portopulmonary hypertension (POPH), pulmonary arterial hypertension (PAH) that develops in the setting of portal hypertension, affects 5%–6% of patients with liver disease and is associated with significant morbidity and mortality. A me
Externí odkaz:
https://doaj.org/article/2dc69ef20740460b9cba137975d3c8b3
Autor:
Michael J. Krowka, Michael D. Leise
Publikováno v:
The Liver in Systemic Disease. :121-132
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b040b8e17ed1452883ff6ae15e616f29
https://doi.org/10.1002/9781119802181.ch10
https://doi.org/10.1002/9781119802181.ch10
Autor:
Hilary M. DuBrock, MD, Reena J. Salgia, MD, Norman L. Sussman, MD, Sonja D. Bartolome, MD, Zakiyah Kadry, MD, David C. Mulligan, MD, Sarah Jenkins, Kandace Lackore, Richard N. Channick, MD, Steven M. Kawut, MD, MS, Michael J. Krowka, MD
Publikováno v:
Transplantation Direct, Vol 5, Iss 6, p e456 (2019)
Background. The role of liver transplantation (LT) in the management of portopulmonary hypertension (POPH) is poorly understood. The aim of this study was to better understand provider attitudes and practice patterns regarding the management of patie
Externí odkaz:
https://doaj.org/article/2a81d3de459145bc9e7fb4f348d82a1c
Autor:
Katherine Cox-Flaherty, Jude Moutchia, Michael J. Krowka, Nadine Al-Naamani, Michael B. Fallon, Hilary DuBrock, Kimberly A. Forde, Karen Krok, Margaret F. Doyle, Steven M. Kawut, Corey E. Ventetuolo
Publikováno v:
Liver Transplantation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b51e72c279998417985639be721c854
https://doi.org/10.1097/lvt.0000000000000071
https://doi.org/10.1097/lvt.0000000000000071
Autor:
Michael J. Krowka, Patrick S. Kamath
Publikováno v:
Liver Transplantation. 29:349-350
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46b5303432e657ddd58ef982d188b48a
https://doi.org/10.1097/lvt.0000000000000078
https://doi.org/10.1097/lvt.0000000000000078
Autor:
Michael J. Krowka, Alice Gallo De Moraes, Vivek N. Iyer, Nadir Demirel, Hector Cajigas, Adham K. Alkurashi, Hillary DuBrock, Holly K. Van Houten, Yahya Almodallal, Lindsey R. Sangaralingham, Deepti M. Warad, Meghan A. Knoedler, Hasan Ahmad Hasan Albitar, Waleed Brinjikji
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 1, Pp 55-64 (2021)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Objective: To assess the health care costs and utilization in patients with hereditary hemorrhagic telangiectasia (HHT) in the United States. Patients and Methods: Retrospective analysis of patients with HHT diagnosed between 2007 and 2017 was perfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::895b0de44b2953fb8b73390f4524d904
http://www.sciencedirect.com/science/article/pii/S2542454820301636
http://www.sciencedirect.com/science/article/pii/S2542454820301636
Autor:
Hilary M. DuBrock, Yogesh N. Reddy, Louise A. Durst, Darrell R. Schroeder, Grace Park, Hector R. Cajigas, Garvan C. Kane, Sudhir S. Kushwaha, Robert B. McCully, Joseph G. Murphy, Vidhu Anand, Michael J. Krowka, Robert P. Frantz
Publikováno v:
Pulmonary circulation. 12(4)
Pulmonary arterial hypertension (PAH) is a progressive pulmonary vascular disease that negatively impacts health-related quality of life (HRQOL). The PAH-symptoms and impact (PAH-SYMPACT) questionnaire is a validated disease-specific patient-reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8961b80bb2e144f0baa0695556ec5472
https://pubmed.ncbi.nlm.nih.gov/36262468
https://pubmed.ncbi.nlm.nih.gov/36262468
Autor:
Aleh Bobr, Melissa R. Snyder, Kevin C. Halling, Maria Alice V. Willrich, Michael J. Krowka, Rondell P. Graham, David L. Murray, Josiah D Murray
Publikováno v:
American Journal of Clinical Pathology. 155:547-552
Objectives Failure to produce sufficient quantities of functional α1-antitrypsin (AAT) can result in AAT deficiency (AATD) and significant comorbidities. Laboratory testing plays a vital role in AATD, with diagnosis requiring documentation of both a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b15546a6757ab80f502b7d164af5b2b1
https://doi.org/10.1093/ajcp/aqaa149
https://doi.org/10.1093/ajcp/aqaa149
Autor:
Hilary M. DuBrock, Michael J. Krowka
Publikováno v:
Hepatology. 72:1455-1460
Portopulmonary hypertension (POPH), defined as an increased mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR) in the setting of portal hypertension, is a commonly misunderstood pulmonary vascular complication of liver dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e61fb7aaf8c70fc5e1be7039c062ef93
https://doi.org/10.1002/hep.31415
https://doi.org/10.1002/hep.31415